Abstract
Aminoacylase 1 (ACY1) deficiency is an organic aciduria due to mutations in the ACY1 gene. It is considered much underdiagnosed. Most individuals known to be affected by ACY1 deficiency have presented with neurologic symptoms. We report here a cognitively normal 63-year-old woman who around the age of 12 years had developed dystonic symptoms that gradually evolved into generalized dystonia. Extensive investigations, including metabolic diagnostics and diagnostic exome sequencing, were performed to elucidate the cause of dystonia. Findings were only compatible with a diagnosis of ACY1 deficiency: the urinary metabolite pattern with N-acetylated amino acids was characteristic, there was decreased ACY1 activity in immortalized lymphocytes, and two compound heterozygous ACY1 mutations were detected, one well-characterized c.1057C>T (p.Arg353Cys) and the other novel c.325A>G (p.Arg109Gly). Expression analysis in HEK293 cells revealed high residual activity of the enzyme with the latter mutation. However, following co-transfection of cells with stable expression of the c.1057C>T variant with either wild-type ACY1 or the c.325A>G mutant, only the wild-type enhanced ACY1 activity and ACY1 presence in the Western blot, suggesting an inhibiting interference between the two variants. Our report extends the clinical spectrum of ACY1 deficiency to include dystonia and indicates that screening for organic acidurias deserves consideration in patients with unexplained generalized dystonia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alessandrì MG, Casarano M, Pezzini I, Doccini S, Nesti C, Cioni G, Battini R (2014) Isolated mild intellectual disability expands the aminoacylase 1 phenotype spectrum. JIMD Rep 16:81–87
Anders MW, Dekant W (1994) Aminoacylases. Adv Pharmacol 27:431–448
Engelke UF, Sass JO, Van Coster RN, Gerlo E, Olbrich H, Krywawych S, Calvin J, Hart C, Omran H, Wevers RA (2008) NMR spectroscopy of aminoacylase 1 deficiency, a novel inborn error of metabolism. NMR Biomed 21:138–147
Ferri L, Funghini S, Fioravanti A, Biondi EG, la Marca G, Guerrini R, Donati MA, Morrone A (2014) Aminoacylase I deficiency due to ACY1 mRNA exon skipping. Clin Genet 86:367–372
Lienhard U, Sass JO (2011) Canavan disease: a neurometabolic disease caused by aspartoacylase deficiency. J Pediatr Sci 3:e71
Lindner H, Hopfner S, Tafler-Naumann M, Miko M, Konrad L, Röhm KH (2000) The distribution of aminoacylase I among mammalian species and localization of the enzyme in porcine kidney. Biochimie 82:129–137
Lindner HA, Lunin VV, Alary A, Hecker R, Cygler M, Ménard R (2003) Essential roles of zinc ligation and enzyme dimerization for catalysis in the aminoacylase-1/M20 family. J Biol Chem 278:44496–44504
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Maceyka M, Nava VE, Milstien S, Spiegel S (2004) Aminoacylase 1 is a sphingosine kinase 1-interacting protein. FEBS Lett 568:30–34
Sass JO, Mohr V, Olbrich H, Engelke U, Horvath J, Fliegauf M, Loges NT, Schweitzer-Krantz S, Moebus R, Weiler P, Kispert A, Superti-Furga A, Wevers RA, Omran H (2006) Mutations in ACY1, the gene encoding aminoacylase 1, cause a novel inborn error of metabolism. Am J Hum Genet 78:401–409
Sass JO, Olbrich H, Mohr V, Hart C, Woldseth B, Krywawych S, Bjurulf B, Lakhani PK, Buchdahl RM, Omran H (2007) Neurological findings in aminoacylase 1 deficiency. Neurology 68:2151–2153
Sass JO, Romrell JS, Vinson SY, Fernandez HH, Fischer J, Rodriguez RL, Okun MS (2009) Tracing the origin of L-2-hydroxyglutaric aciduria in a family. Int J Neurosci 119:2118–2123
Sommer A, Christensen E, Schwenger S, Seul R, Haas D, Olbrich H, Omran H, Sass JO (2011) The molecular basis of aminoacylase 1 deficiency. Biochim Biophys Acta 1812:685–690
Tylki-Szymanska A, Gradowska W, Sommer A, Heer A, Walter M, Reinhard C, Omran H, Sass JO, Jurecka A (2010) Aminoacylase 1 deficiency associated with autistic behavior. J Inherit Metab Dis 33(Suppl 3):S211–S214
van Coster RN, Gerlo EA, Giardina TG, Engelke UF, Smet JE, De Praeter CM, Meersschaut VA, De Meirleir LJ, Seneca SH, Devreese B, Leroy JG, Herga S, Perrier JP, Wevers RA, Lissens W (2005) Aminoacylase I deficiency: a novel inborn error of metabolism. Biochem Biophys Res Commun 338:1322–1326
Wei X, Li J, Xie H, Ling Q, Wang J, Lu D, Zhou L, Xu X, Zheng S (2014) Proteomics-based identification of the tumor suppressor role of aminoacylase 1 in hepatocellular carcinoma. Cancer Lett 351:117–125
Zabel C, Sagi D, Kaindl AM, Steireif N, Kläre Y, Mao L, Peters H, Wacker MA, Kleene R, Klose J (2006) Comparative proteomics in neurodegenerative and non-neurodegenerative diseases suggest nodal point proteins in regulatory networking. J Proteome Res 5:1948–1958
Zhong Y, Onuki J, Yamasaki T, Ogawa O, Akatsuka S, Toyokuni S (2009) Genome-wide analysis identifies a tumor suppressor role for aminoacylase 1 in iron-induced rat renal cell carcinoma. Carcinogenesis 30:158–164
Acknowledgments
J.O. Sass is grateful for financial support by the Hans Hermann Voss-Stiftung (Wipperfürth, Germany) and by the Fondation Claude & Giuliana (Vaduz, Liechtenstein). We thank Drs Malkanthi Fernando and Udo Engelke for organic acid analysis and NMR spectroscopy, respectively, Dr. Erik-Jan Kamsteeg for valuable discussions, and Luzy Bähr, Annegret Flier, Dr. Claudia Till and Kathleen Grundke for excellent technical assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest to declare.
Rights and permissions
About this article
Cite this article
Sass, J.O., Vaithilingam, J., Gemperle-Britschgi, C. et al. Expanding the phenotype in aminoacylase 1 (ACY1) deficiency: characterization of the molecular defect in a 63-year-old woman with generalized dystonia. Metab Brain Dis 31, 587–592 (2016). https://doi.org/10.1007/s11011-015-9778-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-015-9778-6